Gadolinium-enhanced MR imaging in the management of a midline cerebral dysgerminoma.
Magnetic Resonance (MR) imaging has proved to be an excellent modality for the evaluation of CNS tumors and detection of metastatic seeding through CNS pathways. We present a case of cerebral dysgerminoma in which the use of gadopentetate dimeglumine (Gd-DTPA) enhancement added important information in lesion detection and delineation for treatment planning. Our results, and a review of recent literature, suggest that Gd-DTPA-enhanced MR imaging may be useful for initial and follow-up evaluation of CNS dysgerminomas.
Hawes
D R
DR
Department of Radiology, University of Iowa Hospitals and Clinics, Iowa City 52242.
Yuh
W T
WT
Wen
B C
BC
D000293:Adolescent; D002551:Cerebral Ventricle Neoplasms / Q000175:diagnosis*; D003287:Contrast Media; D004338:Drug Combinations; D004407:Dysgerminoma / Q000175:diagnosis*; D019786:Gadolinium DTPA; D006801:Humans; D007089:Image Enhancement; D008279:Magnetic Resonance Imaging; D008297:Male; D008536:Meglumine; D009942:Organometallic Compounds; D010347:Patient Care Planning; D004369:Pentetic Acid; D013012:Sorbitol / Q000031:analogs & derivatives*
D003287:Contrast Media; D004338:Drug Combinations; D009942:Organometallic Compounds; D013012:Sorbitol; D008536:Meglumine; D004369:Pentetic Acid; D019786:Gadolinium DTPA